BofA Upgrades Biocryst Pharma; Optimistic About Next Gen Drug By: Benzinga via Benzinga June 30, 2015 at 08:48 AM EDT In a report published Tuesday, BofA Merrill Lynch analyst Tazeen Ahmad upgraded the rating on BioCryst Pharmaceuticals, Inc. (NASDAQ: ... Read More >> Related Stocks: Biocryst Pharma Inc